1. Home
  2. WGS vs UTG Comparison

WGS vs UTG Comparison

Compare WGS & UTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

N/A

Current Price

$45.89

Market Cap

2.7B

Sector

Technology

ML Signal

N/A

Logo Reaves Utility Income Fund of Beneficial Interest

UTG

Reaves Utility Income Fund of Beneficial Interest

N/A

Current Price

$30.45

Market Cap

2.9B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
WGS
UTG
Founded
2017
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Investment Managers
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.9B
IPO Year
2020
2003

Fundamental Metrics

Financial Performance
Metric
WGS
UTG
Price
$45.89
$30.45
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
★ $82.00
N/A
AVG Volume (30 Days)
★ 1.1M
393.5K
Earning Date
11-09-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
★ 62.37
N/A
EPS
N/A
★ N/A
Revenue
★ $427,539,000.00
N/A
Revenue This Year
$11.40
N/A
Revenue Next Year
$19.61
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 39.97
N/A
52 Week Low
$32.21
$30.96
52 Week High
$170.87
$43.90

Technical Indicators

Market Signals
Indicator
WGS
UTG
Relative Strength Index (RSI) 33.81 28.05
Support Level $32.21 N/A
Resistance Level $72.65 $35.07
Average True Range (ATR) 5.39 0.88
MACD -0.98 -0.29
Stochastic Oscillator 4.82 5.48

Price Performance

Historical Comparison
WGS
UTG

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

About UTG Reaves Utility Income Fund of Beneficial Interest

Reaves Utility Income Fund is a closed-end management investment company. The company's investment objective is to provide a high level of after-tax income and total return consisting of tax-advantaged dividend income and capital appreciation. It invests a portion of its total assets in securities of utility companies, which may include companies in the electric, gas, water, telecommunications sectors, as well as other companies engaged in other infrastructure operations.

Share on Social Networks: